Gujarat Terce Laboratories Ltd — Important, 03-06-2026: Company Update

Gujarat Terce Laboratories has released its Investor Presentation for the fourth quarter and full year ended March 31, 2026. For FY26, the company reported revenue of ₹47.47 Cr, a 5% decline, but achieved a significant 325% increase in reported PAT to ₹2.20 Cr, turning profitable from a prior year loss. EBITDA for FY26 stood at ₹3.63 Cr, down 13%. Q4 FY26 revenue was ₹11.40 Cr, an 8% dip, with EBITDA at ₹0.37 Cr, down 68%. Despite Q4 challenges, the quarter ended with a positive PAT of ₹0.10 Cr. Management emphasized strengthening fundamentals, operational efficiency, and financial discipline, leading to over 50% net worth growth and positioning for sustainable value creation.